{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T08:52:16Z","timestamp":1788079936860,"version":"build-2784847793"},"reference-count":30,"publisher":"Massachusetts Medical Society","issue":"4","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2024,7,25]]},"DOI":"10.1056\/nejmoa2401755","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T04:30:21Z","timestamp":1717734621000},"page":"311-319","source":"Crossref","is-referenced-by-count":481,"title":["A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis"],"prefix":"10.1056","volume":"391","author":[{"given":"Arun J.","family":"Sanyal","sequence":"first","affiliation":[{"name":"From the Stravitz\u2013Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond (A.J.S.); Liverpat and University of Paris (P.B.), and Sorbonne Universit\u00e9, Institute for Cardiometabolism and Nutrition, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM Unit\u00e9 Mixte de Recherche Scientifique 1138, Centre de Recherche des Cordeliers (V.R.) \u2014 all in Paris; Boehringer Ingelheim, Ingelheim am Rhein (M.F., S.A.H and R.Y.), Saarland University Medical Center, Homburg (J.M.S.), and University of the Saarland, Saarbr\u00fccken (J.M.S.) \u2014 all in Germany; Covenant Metabolic Specialists, Sarasota, FL (G.W.N.); Houston Methodist Hospital and Houston Research Institute, Houston (M.N.), and the Texas Liver Institute, University of Texas Health San Antonio, San Antonio (E.L. and N.A.) \u2014 all in Texas; the University of Turin, Turin, Italy (E.B.); the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, and Newcastle National Institut..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bedossa","sequence":"additional","affiliation":[{"name":"From the Stravitz\u2013Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond (A.J.S.); Liverpat and University of Paris (P.B.), and Sorbonne Universit\u00e9, Institute for Cardiometabolism and Nutrition, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM Unit\u00e9 Mixte de Recherche Scientifique 1138, Centre de Recherche des Cordeliers (V.R.) \u2014 all in Paris; Boehringer Ingelheim, Ingelheim am Rhein (M.F., S.A.H and R.Y.), Saarland University Medical Center, Homburg (J.M.S.), and University of the Saarland, Saarbr\u00fccken (J.M.S.) \u2014 all in Germany; Covenant Metabolic Specialists, Sarasota, FL (G.W.N.); Houston Methodist Hospital and Houston Research Institute, Houston (M.N.), and the Texas Liver Institute, University of Texas Health San Antonio, San Antonio (E.L. and N.A.) \u2014 all in Texas; the University of Turin, Turin, Italy (E.B.); the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, and Newcastle National Institut..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Fraessdorf","sequence":"additional","affiliation":[{"name":"From the Stravitz\u2013Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond (A.J.S.); Liverpat and University of Paris (P.B.), and Sorbonne Universit\u00e9, Institute for Cardiometabolism and Nutrition, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM Unit\u00e9 Mixte de Recherche Scientifique 1138, Centre de Recherche des Cordeliers (V.R.) \u2014 all in Paris; Boehringer Ingelheim, Ingelheim am Rhein (M.F., S.A.H and R.Y.), Saarland University Medical Center, Homburg (J.M.S.), and University of the Saarland, Saarbr\u00fccken (J.M.S.) \u2014 all in Germany; Covenant Metabolic Specialists, Sarasota, FL (G.W.N.); Houston Methodist Hospital and Houston Research Institute, Houston (M.N.), and the Texas Liver Institute, University of Texas Health San Antonio, San Antonio (E.L. and N.A.) \u2014 all in Texas; the University of Turin, Turin, Italy (E.B.); the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, and Newcastle National Institut..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy W.","family":"Neff","sequence":"additional","affiliation":[{"name":"From the Stravitz\u2013Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond (A.J.S.); Liverpat and University of Paris (P.B.), and Sorbonne Universit\u00e9, Institute for Cardiometabolism and Nutrition, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM Unit\u00e9 Mixte de Recherche Scientifique 1138, Centre de Recherche des Cordeliers (V.R.) \u2014 all in Paris; Boehringer Ingelheim, Ingelheim am Rhein (M.F., S.A.H and R.Y.), Saarland University Medical Center, Homburg (J.M.S.), and University of the Saarland, Saarbr\u00fccken (J.M.S.) \u2014 all in Germany; Covenant Metabolic Specialists, Sarasota, FL (G.W.N.); Houston Methodist Hospital and Houston Research Institute, Houston (M.N.), and the Texas Liver Institute, University of Texas Health San Antonio, San Antonio (E.L. and N.A.) \u2014 all in Texas; the University of Turin, Turin, Italy (E.B.); the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, and Newcastle National Institut..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lawitz","sequence":"additional","affiliation":[{"name":"From the Stravitz\u2013Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond (A.J.S.); Liverpat and University of Paris (P.B.), and Sorbonne Universit\u00e9, Institute for Cardiometabolism and Nutrition, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM Unit\u00e9 Mixte de Recherche Scientifique 1138, Centre de Recherche des Cordeliers (V.R.) \u2014 all in Paris; Boehringer Ingelheim, Ingelheim am Rhein (M.F., S.A.H and R.Y.), Saarland University Medical Center, Homburg (J.M.S.), and University of the Saarland, Saarbr\u00fccken (J.M.S.) \u2014 all in Germany; Covenant Metabolic Specialists, Sarasota, FL (G.W.N.); Houston Methodist Hospital and Houston Research Institute, Houston (M.N.), and the Texas Liver Institute, University of Texas Health San Antonio, San Antonio (E.L. and N.A.) \u2014 all in Texas; the University of Turin, Turin, Italy (E.B.); the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, and Newcastle National Institut..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bugianesi","sequence":"additional","affiliation":[{"name":"From the Stravitz\u2013Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond (A.J.S.); Liverpat and University of Paris (P.B.), and Sorbonne Universit\u00e9, Institute for Cardiometabolism and Nutrition, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM Unit\u00e9 Mixte de Recherche Scientifique 1138, Centre de Recherche des Cordeliers (V.R.) \u2014 all in Paris; Boehringer Ingelheim, Ingelheim am Rhein (M.F., S.A.H and R.Y.), Saarland University Medical Center, Homburg (J.M.S.), and University of the Saarland, Saarbr\u00fccken (J.M.S.) \u2014 all in Germany; Covenant Metabolic Specialists, Sarasota, FL (G.W.N.); Houston Methodist Hospital and Houston Research Institute, Houston (M.N.), and the Texas Liver Institute, University of Texas Health San Antonio, San Antonio (E.L. and N.A.) \u2014 all in Texas; the University of Turin, Turin, Italy (E.B.); the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, and Newcastle National Institut..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin M.","family":"Anstee","sequence":"additional","affiliation":[{"name":"From the Stravitz\u2013Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond (A.J.S.); Liverpat and University of Paris (P.B.), and Sorbonne Universit\u00e9, Institute for Cardiometabolism and Nutrition, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM Unit\u00e9 Mixte de Recherche Scientifique 1138, Centre de Recherche des Cordeliers (V.R.) \u2014 all in Paris; Boehringer Ingelheim, Ingelheim am Rhein (M.F., S.A.H and R.Y.), Saarland University Medical Center, Homburg (J.M.S.), and University of the Saarland, Saarbr\u00fccken (J.M.S.) \u2014 all in Germany; Covenant Metabolic Specialists, Sarasota, FL (G.W.N.); Houston Methodist Hospital and Houston Research Institute, Houston (M.N.), and the Texas Liver Institute, University of Texas Health San Antonio, San Antonio (E.L. and N.A.) \u2014 all in Texas; the University of Turin, Turin, Italy (E.B.); the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, and Newcastle National Institut..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samina Ajaz","family":"Hussain","sequence":"additional","affiliation":[{"name":"From the Stravitz\u2013Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond (A.J.S.); Liverpat and University of Paris (P.B.), and Sorbonne Universit\u00e9, Institute for Cardiometabolism and Nutrition, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM Unit\u00e9 Mixte de Recherche Scientifique 1138, Centre de Recherche des Cordeliers (V.R.) \u2014 all in Paris; Boehringer Ingelheim, Ingelheim am Rhein (M.F., S.A.H and R.Y.), Saarland University Medical Center, Homburg (J.M.S.), and University of the Saarland, Saarbr\u00fccken (J.M.S.) \u2014 all in Germany; Covenant Metabolic Specialists, Sarasota, FL (G.W.N.); Houston Methodist Hospital and Houston Research Institute, Houston (M.N.), and the Texas Liver Institute, University of Texas Health San Antonio, San Antonio (E.L. and N.A.) \u2014 all in Texas; the University of Turin, Turin, Italy (E.B.); the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, and Newcastle National Institut..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6085-3652","authenticated-orcid":false,"given":"Philip N.","family":"Newsome","sequence":"additional","affiliation":[{"name":"From the Stravitz\u2013Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond (A.J.S.); Liverpat and University of Paris (P.B.), and Sorbonne Universit\u00e9, Institute for Cardiometabolism and Nutrition, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM Unit\u00e9 Mixte de Recherche Scientifique 1138, Centre de Recherche des Cordeliers (V.R.) \u2014 all in Paris; Boehringer Ingelheim, Ingelheim am Rhein (M.F., S.A.H and R.Y.), Saarland University Medical Center, Homburg (J.M.S.), and University of the Saarland, Saarbr\u00fccken (J.M.S.) \u2014 all in Germany; Covenant Metabolic Specialists, Sarasota, FL (G.W.N.); Houston Methodist Hospital and Houston Research Institute, Houston (M.N.), and the Texas Liver Institute, University of Texas Health San Antonio, San Antonio (E.L. and N.A.) \u2014 all in Texas; the University of Turin, Turin, Italy (E.B.); the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, and Newcastle National Institut..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Ratziu","sequence":"additional","affiliation":[{"name":"From the Stravitz\u2013Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond (A.J.S.); Liverpat and University of Paris (P.B.), and Sorbonne Universit\u00e9, Institute for Cardiometabolism and Nutrition, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM Unit\u00e9 Mixte de Recherche Scientifique 1138, Centre de Recherche des Cordeliers (V.R.) \u2014 all in Paris; Boehringer Ingelheim, Ingelheim am Rhein (M.F., S.A.H and R.Y.), Saarland University Medical Center, Homburg (J.M.S.), and University of the Saarland, Saarbr\u00fccken (J.M.S.) \u2014 all in Germany; Covenant Metabolic Specialists, Sarasota, FL (G.W.N.); Houston Methodist Hospital and Houston Research Institute, Houston (M.N.), and the Texas Liver Institute, University of Texas Health San Antonio, San Antonio (E.L. and N.A.) \u2014 all in Texas; the University of Turin, Turin, Italy (E.B.); the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, and Newcastle National Institut..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Hosseini-Tabatabaei","sequence":"additional","affiliation":[{"name":"From the Stravitz\u2013Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond (A.J.S.); Liverpat and University of Paris (P.B.), and Sorbonne Universit\u00e9, Institute for Cardiometabolism and Nutrition, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM Unit\u00e9 Mixte de Recherche Scientifique 1138, Centre de Recherche des Cordeliers (V.R.) \u2014 all in Paris; Boehringer Ingelheim, Ingelheim am Rhein (M.F., S.A.H and R.Y.), Saarland University Medical Center, Homburg (J.M.S.), and University of the Saarland, Saarbr\u00fccken (J.M.S.) \u2014 all in Germany; Covenant Metabolic Specialists, Sarasota, FL (G.W.N.); Houston Methodist Hospital and Houston Research Institute, Houston (M.N.), and the Texas Liver Institute, University of Texas Health San Antonio, San Antonio (E.L. and N.A.) \u2014 all in Texas; the University of Turin, Turin, Italy (E.B.); the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, and Newcastle National Institut..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4224-4703","authenticated-orcid":false,"given":"J\u00f6rn M.","family":"Schattenberg","sequence":"additional","affiliation":[{"name":"From the Stravitz\u2013Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond (A.J.S.); Liverpat and University of Paris (P.B.), and Sorbonne Universit\u00e9, Institute for Cardiometabolism and Nutrition, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM Unit\u00e9 Mixte de Recherche Scientifique 1138, Centre de Recherche des Cordeliers (V.R.) \u2014 all in Paris; Boehringer Ingelheim, Ingelheim am Rhein (M.F., S.A.H and R.Y.), Saarland University Medical Center, Homburg (J.M.S.), and University of the Saarland, Saarbr\u00fccken (J.M.S.) \u2014 all in Germany; Covenant Metabolic Specialists, Sarasota, FL (G.W.N.); Houston Methodist Hospital and Houston Research Institute, Houston (M.N.), and the Texas Liver Institute, University of Texas Health San Antonio, San Antonio (E.L. and N.A.) \u2014 all in Texas; the University of Turin, Turin, Italy (E.B.); the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, and Newcastle National Institut..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Noureddin","sequence":"additional","affiliation":[{"name":"From the Stravitz\u2013Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond (A.J.S.); Liverpat and University of Paris (P.B.), and Sorbonne Universit\u00e9, Institute for Cardiometabolism and Nutrition, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM Unit\u00e9 Mixte de Recherche Scientifique 1138, Centre de Recherche des Cordeliers (V.R.) \u2014 all in Paris; Boehringer Ingelheim, Ingelheim am Rhein (M.F., S.A.H and R.Y.), Saarland University Medical Center, Homburg (J.M.S.), and University of the Saarland, Saarbr\u00fccken (J.M.S.) \u2014 all in Germany; Covenant Metabolic Specialists, Sarasota, FL (G.W.N.); Houston Methodist Hospital and Houston Research Institute, Houston (M.N.), and the Texas Liver Institute, University of Texas Health San Antonio, San Antonio (E.L. and N.A.) \u2014 all in Texas; the University of Turin, Turin, Italy (E.B.); the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, and Newcastle National Institut..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9872-2391","authenticated-orcid":false,"given":"Naim","family":"Alkhouri","sequence":"additional","affiliation":[{"name":"From the Stravitz\u2013Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond (A.J.S.); Liverpat and University of Paris (P.B.), and Sorbonne Universit\u00e9, Institute for Cardiometabolism and Nutrition, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM Unit\u00e9 Mixte de Recherche Scientifique 1138, Centre de Recherche des Cordeliers (V.R.) \u2014 all in Paris; Boehringer Ingelheim, Ingelheim am Rhein (M.F., S.A.H and R.Y.), Saarland University Medical Center, Homburg (J.M.S.), and University of the Saarland, Saarbr\u00fccken (J.M.S.) \u2014 all in Germany; Covenant Metabolic Specialists, Sarasota, FL (G.W.N.); Houston Methodist Hospital and Houston Research Institute, Houston (M.N.), and the Texas Liver Institute, University of Texas Health San Antonio, San Antonio (E.L. and N.A.) \u2014 all in Texas; the University of Turin, Turin, Italy (E.B.); the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, and Newcastle National Institut..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy","family":"Younes","sequence":"additional","affiliation":[{"name":"From the Stravitz\u2013Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond (A.J.S.); Liverpat and University of Paris (P.B.), and Sorbonne Universit\u00e9, Institute for Cardiometabolism and Nutrition, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM Unit\u00e9 Mixte de Recherche Scientifique 1138, Centre de Recherche des Cordeliers (V.R.) \u2014 all in Paris; Boehringer Ingelheim, Ingelheim am Rhein (M.F., S.A.H and R.Y.), Saarland University Medical Center, Homburg (J.M.S.), and University of the Saarland, Saarbr\u00fccken (J.M.S.) \u2014 all in Germany; Covenant Metabolic Specialists, Sarasota, FL (G.W.N.); Houston Methodist Hospital and Houston Research Institute, Houston (M.N.), and the Texas Liver Institute, University of Texas Health San Antonio, San Antonio (E.L. and N.A.) \u2014 all in Texas; the University of Turin, Turin, Italy (E.B.); the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, and Newcastle National Institut..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.06.023"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.040"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.04.036"},{"key":"e_1_3_5_6_2","unstructured":"FDA approves first treatment for patients with liver scarring due to fatty liver disease. Food and Drug Administration March 14 2024 (https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease)."},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309000"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.03.041"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-00960-3"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0242"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.209"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73815-5"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0797"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4354-8"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00649"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120188"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101633"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(23)00356-X"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28962"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.030"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2304286"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.014"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/10543400600860428"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0278"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028395"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12735"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-2151"},{"key":"e_1_3_5_30_2","unstructured":"Adams B. GI toxicity hits midstage Sanofi GLP-1 drug as patients drop out. Fierce Biotech April 27 2018 (https:\/\/www.fiercebiotech.com\/biotech\/gi-toxicity-hits-midstage-poc-sanofi-glp-1-drug-as-patients-drop-out)."},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101801"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2401755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T18:37:45Z","timestamp":1749667065000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2401755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7,25]]}},"alternative-id":["10.1056\/NEJMoa2401755"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2401755","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]}}}